1. Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro
- Author
-
Mahmoud A. Ghannoum, Jyotsna Chandra, Pranab K. Mukherjee, S. D. Leidich, L. J. Douglas, Fady F. Faddoul, and Lois L. Hoyer
- Subjects
0301 basic medicine ,Denture Bases ,Nystatin ,Sucrose ,Antifungal Agents ,Time Factors ,Statistics as Topic ,Acrylic Resins ,Colony Count, Microbial ,Tetrazolium Salts ,Microbiology ,03 medical and health sciences ,0302 clinical medicine ,Candidiasis, Oral ,Amphotericin B ,Candida albicans ,medicine ,Humans ,Polymethyl Methacrylate ,Saliva ,Fluconazole ,General Dentistry ,Stomatitis ,Dose-Response Relationship, Drug ,Chemistry ,Chlorhexidine ,Biofilm ,Galactose ,Drug Resistance, Microbial ,030206 dentistry ,medicine.disease ,Stomatitis, Denture ,Corpus albicans ,In vitro ,Glucose ,030104 developmental biology ,Biofilms ,Anti-Infective Agents, Local ,Indicators and Reagents ,medicine.drug - Abstract
Denture biofilms represent a protective reservoir for oral microbes. The study of the biology of Candida in these biofilms requires a reliable model. A reproducible model of C. albicans denture biofilm was developed and used to determine the susceptibility of two clinically relevant C. albicans isolates against 4 antifungals. C. albicans, growing as a biofilm, exhibited resistance to amphotericin B, nystatin, chlorhexidine, and fluconazole, with 50% reduction in metabolic activity (50% RMA) at concentrations of 8, 16, 128, and > 64 μg/mL, respectively. In contrast, planktonically cultured C. albicans were susceptible (50% RMA for the same antifungals was obtained at 0.25, 1.0, 4.0, and 0.5 μg/mL, respectively). In conclusion, results obtained by means of our biofilm model show that biofilm-associated C. albicans cells, compared with cells grown in planktonic form, are resistant to antifungals used to treat denture stomatitis.
- Published
- 2001
- Full Text
- View/download PDF